Synaptosomal-associated protein 25 mutation induces immaturity of the dentate granule cells of adult mice by Koji Ohira et al.
Ohira et al. Molecular Brain 2013, 6:12
http://www.molecularbrain.com/content/6/1/12RESEARCH Open AccessSynaptosomal-associated protein 25 mutation
induces immaturity of the dentate granule cells
of adult mice
Koji Ohira1,2, Katsunori Kobayashi2,3, Keiko Toyama1,2, Hironori K Nakamura1,2, Hirotaka Shoji1,2, Keizo Takao2,4,
Rika Takeuchi1,2, Shun Yamaguchi5,6, Masakazu Kataoka7, Shintaro Otsuka8, Masami Takahashi8
and Tsuyoshi Miyakawa1,2,4*Abstract
Background: Synaptosomal-associated protein, 25 kDa (SNAP-25) regulates the exocytosis of neurotransmitters.
Growing evidence suggests that SNAP-25 is involved in neuropsychiatric disorders, such as schizophrenia,
attention-deficit/hyperactivity disorder, and epilepsy. Recently, increases in anxiety-related behaviors and epilepsy
have been observed in SNAP-25 knock-in (KI) mice, which have a single amino acid substitution of Ala for Ser187.
However, the molecular and cellular mechanisms underlying the abnormalities in this mutant remain unknown.
Results: In this study, we found that a significant number of dentate gyrus (DG) granule cells was histologically and
electrophysiologically similar to immature DG neurons in the dentate gyrus of the adult mutants, a phenomenon
termed the “immature DG” (iDG). SNAP-25 KI mice and other mice possessing the iDG phenotype, i.e., alpha-
calcium/calmodulin-dependent protein kinase II heterozygous mice, Schnurri-2 knockout mice, and mice treated
with the antidepressant fluoxetine, showed similar molecular expression patterns, with over 100 genes similarly
altered. A working memory deficit was also identified in mutant mice during a spontaneous forced alternation task
using a modified T-maze, a behavioral task known to be dependent on hippocampal function. Chronic treatments
with the antiepileptic drug valproate abolished the iDG phenotype and the working memory deficit in mutants.
Conclusions: These findings suggest that the substitution of Ala for Ser187 in SNAP-25 induces the iDG phenotype,
which can also be caused by epilepsy, and led to a severe working memory deficit. In addition, the iDG phenotype
in adulthood is likely an endophenotype for at least a part of some common psychiatric disorders.
Keywords: Epileptic seizure, Granule cell, Hippocampus, Immature dentate gyrus, Psychiatric disorder, Working
memoryBackground
Synaptosomal-associated protein, 25 kDa (SNAP-25) is a
soluble N-ethylmaleimide-sensitive factor attachment
protein receptor (SNARE) protein that plays a pivotal
role in regulating synaptic vesicle exocytosis [1-4]. In
humans, several studies have suggested that SNAP-25 is
involved in the verbal and performance intelligence quo-
tient [5-7], learning, and memory [8,9]. A family-based* Correspondence: miyakawa@fujita-hu.ac.jp
1Division of Systems Medical Science, Institute for Comprehensive Medical
Science, Fujita Health University, Toyoake 470-1192, Japan
2Japan Science and Technology Agency (JST), Core Research for Evolutional
Science and Technology (CREST), Kawaguchi 332-0012, Japan
Full list of author information is available at the end of the article
© 2013 Ohira et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the orstudy found that 3 single-nucleotide polymorphisms
(SNPs: rs363039, rs363050, and rs362602) in the SNAP-
25 gene are associated with the intelligence quotient
[5,6]. One of these SNPs, rs363039, is associated with
working memory capacity [7]. Additional SNPs at DdeI
(rs1051312) [8] and MnlI (rs3746544) [9] can affect
working, verbal, and visual memory as well as attention/
executive functions. In experimental animal studies,
SNAP-25 mRNA levels increase after induction of long-
term potentiation (LTP) in the granule cells of the
dentate gyrus (DG) [10]. Inhibition of hippocampal
SNAP-25 results in impairment of long-term contextual
fear and spatial memories and a decrease in LTP [11].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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prevents axon elongation and the transformation of
growth cones into synaptic terminals [12], especially in
hippocampal neurons [13].
Recent human genetic studies have discovered associa-
tions between SNAP-25 and various psychiatric and
neurological disorders, such as schizophrenia [14-17],
attention-deficit/hyperactivity disorder (ADHD) [18-24],
and epilepsy [25-29]. Moreover, translational convergent
functional genomics has demonstrated that SNAP-25 is
one of top 42 candidate genes for schizophrenia [30].
Using a dominant-negative SNAP-25 mutant (SNAP-25
knock-in [KI] mice), in which Ser187 is replaced with
Ala, we have previously shown that this mutation results
in an increase in anxiety-like behaviors and epileptic
seizures [29]. However, it remains unknown how this
specific SNAP-25 mutation affects the neuronal properties
and functions of the brain. The current study addresses
this question using histological, gene expression, and
electrophysiological analyses in SNAP-25 KI mice.
Results
Immature state in DG cells in SNAP-25 KI mice
Using Nissl staining and immunohistochemistry for
NeuN, the cytoarchitecture of the brains of SNAP-25 KI
mice was examined for abnormalities. In Nissl-stained
sections, few differences were detected between mutant
and control mice in terms of the cytoarchitecture of all
brain regions examined, except in the hippocampus
(Additional file 1: Figure S1A). Interestingly, the size of
the hippocampal DG was significantly larger in mutants
than in control mice (p < 0.0001; Additional file 1: Figure
S1). The size of the hilus region was expanded in the DG
of mutant mice. However, there was no obvious difference
in the thicknesses of the granule cell layer (GCL) between
controls and mutants. Although the mechanism that
enlarges the DG region of mutants remains unclear, it is
unlikely to involve alteration of adult neurogenesis, which
was significantly decreased in mutant mice, as described
in detail below (see Figure 1 and Additional file 1: Figure
S3). However, it is possible that increased neurogenesis
and/or gliogenesis during development and/or decreased
cell death during development and adulthood may
account for these effects. When stained with a neuron
marker, NeuN, NeuN immunoreactivity in the DG of mu-
tants was reduced to 60% of the control level (p < 0.0001;
Additional file 1: Figure S1). The NeuN immunoreactivity
seemed to be expressed at lower levels in individual gran-
ule cells in the DG of mutants (Additional file 1: Figure
S1B, C). This decrease in NeuN immunoreactivity was not
detected in other brain regions, such as the frontal cortex
(p = 0.863), motor cortex (p = 0.742), somatosensory
cortex (p = 0.928), striatum (p = 0.822), and thalamus
(p = 0.673).Next, expressions of various cell markers were exam-
ined during neural cell development in the hippocam-
pus, where adult neurogenesis occurs throughout life
[31]. Neural stem cells exist near the subgranular zone,
which is located between the hilus and the GCL.
Neuroblasts generated in the subgranular zone are inte-
grated into the deepest portion of the GCL, where they
differentiate into granule cells and extend dendrites and
axons [31]. During their development, new granule cells
express various protein markers depending on the stage
of cellular differentiation (Additional file 1: Figure S2).
The fluorescence intensities of the mature granule cell
marker calbindin were dramatically decreased in the DG
and CA1 of mutants to 30% and 56% of control levels,
respectively (Figure 2A, C). There were no significant
differences between controls and mutants in the num-
bers of calbindin-positive cells in the DG molecular
layer, hilus, CA1, and CA3 (p > 0.25). The number of
cells positive for calretinin, an immature granule cell
marker, in the GCL was significantly increased in mu-
tants (Figure 2A, E). However, there were no significant
differences between the mutants and controls in the
numbers of calretinin-positive cells in the CA1 and CA3
regions, but there was a significant increase in the num-
ber of calretinin-positive cells in the hilus of mutants
compared with that of controls (Figure 2E).
Because there was an increase in the number of imma-
ture granule cells in the GCL of mutants, adult hippo-
campal neurogenesis was evaluated using the cell
proliferation markers Ki67 and bromodeoxyuridine
(BrdU) and the late progenitor and early newborn
granule cell marker doublecortin (DCX). In the DG of
mutants injected with BrdU 3 days before perfusion, the
numbers of BrdU- and Ki67-positive cells were signifi-
cantly reduced (Figure 1A, B and Additional file 1:
Figure S3). The number of DCX-positive cells was also
significantly reduced in the mutants (Figure 1C–E).
These findings indicate that adult hippocampal neuro-
genesis was decreased in the mutants.
The distribution of calretinin-positive cells within the
GCL of mutants was also examined (Figure 2A).
Calretinin-positive immature granule cells were primar-
ily located in the subgranular zone (Figure 2A, bottom
left). Because calretinin is also expressed in interneu-
rons, which may be mislocated in mutant GCL, the
distribution of immature granule cells in the DG was
confirmed using DCX immunostaining [31]. As ex-
pected, DCX-positive immature granule cells were
observed within the GCL (Figure 1C, D, F). As shown in
Figure 2, the number of calretinin-positive immature
granule cells was increased, and almost all of the granule
cells in mutant mice were immunonegative for calbindin.
These results suggest that the dentate granule cells




Figure 1 Decrease in adult hippocampal neurogenesis in mutant mice. (A, B) Cell proliferation was analyzed using BrdU staining (n = 6 mice
each). Arrowheads indicate BrdU-positive cells. (C, D) Images of doublecortin (DCX)-positive cells (arrowheads) in the GCL are shown. ML, molecular
layer. SGZ, subgranular zone. HL, hilus. (E) Quantification of DCX-positive cell numbers in the GCL (n = 4 mice each). (F) The positions of DCX-positive
cells are shown as relative values between the subgranular layer (SGL; 0) and the border with the molecular layer (ML; 1) (n = 4 mice each).
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reversal in maturation status (dematuration) [33].
Transcriptome analysis of the DG of SNAP-25 KI mice
Previously, a method was established to reliably identify
the immature DG (iDG) phenotype using a characteristic
expression pattern of 3 genes [32-35], including the
upregulation of dopamine receptor D1A (DRD1A) andthe downregulation of desmoplakin (DSP) and tryptophan
2,3-dioxygenase (TDO2). Therefore, the mRNA expression
patterns of DRD1A, DSP, and TDO2 were examined in the
hippocampi of mutant mice using quantitative real-time
PCR analysis. A significant increase in DRD1A mRNA
expression and significant decreases in DSP and TDO2
mRNA expression were detected in mutants (Figure 3D),
indicating that SNAP-25 KI mice have the iDG phenotype.
Figure 2 Decreases in the expression levels of mature granule cell markers in mutant mice. (A) Immunoreactivity for calbindin (green), a
mature granule cell marker, and calretinin (green), an immature granule cell marker. The dotted line illustrates the border between the GCL and
the hilus. (B) Definition of the hippocampal subregions measured in C–E. (C–E) Quantification of calbindin- and calretinin-positive cells in the
hippocampal regions (n = 4 mice each) is shown.
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isoform of calcium/calmodulin-dependent protein kinase
II (αCaMKII) heterozygous knockout (HKO) mice
[32,34-36], Schnurri-2 (Shn-2) KO mice [37], and chronic
fluoxetine (FLX)-treated mice [33,38,39]. To elucidate the
molecular mechanisms responsible for the iDG phenotype
in SNAP-25 KI mice, DNA microarray analysis was
performed using the hippocampi of mutant mice. From
this analysis, significant up- or downregulation of 4587
genes was detected in the mutant (p < 0.05, fold-change
(FC) < –1.2 or > 1.2). The transcriptome patterns in the
hippocampi of SNAP-25 KI mice were then compared
with those patterns in αCaMKII HKO mice, Shn-2 KOmice, and FLX-treated mice. Hippocampal gene expres-
sion data was obtained for αCaMKII HKO mice (data
available publicly on ArrayExpress, http://www.ebi.ac.uk/
arrayexpress/, accession number: E-MEXP-962) [32], for
Shn-2 KO mice [37], and for FLX-treated mice (obtained
from Gene Expression Omnibus, http://www.ncbi.nlm.
nih.gov/geo/, accession number: GSE6476) [40]. The data
for Shn-2 KO mice has been submitted for publication by
Takao et al. [37] and will be available on the ArrayExpress
database in the near future (accession number: GSE41307).
Interestingly, SNAP-25 KI mice and other mice possessing
the iDG phenotype, especially the FLX-treated mice, had
similar gene expression patterns (Figure 3A–C), with more
Figure 3 iDG phenotype and severe working memory deficit in SNAP-25 KI mice. (A–C) Scatter plot illustrating the fold change (FC) values
for gene expression levels in the hippocampi of SNAP-25 KI mice (control: n = 7 mice, KI: n = 6 mice) and FLX-treated (A), Shn-2 KO (B), or
αCaMKII HKO mice (C), which have the iDG phenotype. (D) mRNA expression analysis of DRD1A, DSP, and TDO2, which identify the iDG
phenotype, using real-time PCR (control: n = 7 mice, KI: n = 9 mice). (E, F) The somatic physiological properties of granule cells in the DG of
control (n = 22) and SNAP-25 KI mice (n = 21) are shown. (E) Sample recordings of granule cell action potentials evoked by depolarizing current
pulses are shown. (F) Pooled data showing the resting membrane potential, input resistance, spike threshold current, and maximal number of
spikes during sustained depolarization. (G) EPSP-to-fiber volley ratio (control: n = 9, KI: n = 8), synaptic potentiation induced by 10 μM dopamine
(control: n = 5, KI: n = 4), and the frequency facilitation induced by a 1-Hz stimulation (control: n = 8, KI: n = 7) at the mossy fiber synapse are
shown. (H) Severe working memory deficits were observed in SNAP-25 KI mice during a spontaneous alternation task in the T-maze (control:
n = 9 mice, KI: n = 7 mice).
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genes satisfying the threshold for statistical signi-
ficance, i.e., p < 0.01 and |FC| > 1.2, are plotted in
Figure 3A–C (see Additional file 2 for the list of
genes plotted in Figure 3A–C). The strongest correl-
ation was identified between the gene expression data
of SNAP-25 KI mice and FLX-treated mice (r = 0.92,
p < 0.001; SNAP-25 KI vs. Shn-2 KO mice, r = 0.45,
p < 0.001; SNAP-25 KI vs. αCaMKII HKO mice, r = 0.24,
p = 0.012). Moreover, the fold changes in gene expression
were remarkably similar between SNAP-25 KI mice and
FLX-treated mice. These results indicate that similar
molecular events may occur in SNAP-25 KI and FLX-
treated mice.Granule cells in SNAP-25 KI mice exhibited immature
functional features
Given that the molecular expression data reflects a
change in the state of granule cell maturation in SNAP-
25 KI mice, it was assumed that these cells were also
functionally altered. Therefore, the electrophysiological
properties of mutant granule cells were also examined.
When compared with mature cells, young granule cells
are more easily excited by somatic current injection
[41,42]. Whole-cell current clamp recordings from gran-
ule cells revealed that mutant granule cells had a
depolarized resting membrane potential and an intact
input resistance (Figure 3E, F). Mutant granule cells
appeared to have a lower threshold current for firing
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depolarization in response to the current injection.
Thus, SNAP-25 KI granule cells were more excitable
(Figure 3E, F).
The properties of the dentate-to-CA3 signal transmis-
sion mediated by mossy fibers (MFs), which are the
axons of granule cells, were then examined. There was
no significant change in the basal synaptic efficacy
(Figure 3G). Consistent with the upregulation of DRD1
mRNA, dopamine-induced synaptic potentiation was
enhanced in mutant mice (Figure 3G). The prominent
frequency facilitation, presynaptic short-term plasticity
that is characteristic of mature MF synapses, was greatly
decreased in mutants (Figure 3G). These changes are
very similar to the changes observed in mice treated
with FLX, which exhibit a “dematurated” DG [33,38].
Taken together, these results suggest that the granule
cells in SNAP-25 KI mice have physiological properties
that are characteristic of immature cells.
Severe working memory deficit in SNAP-25 KI mice
Previous reports have shown that SNAP-25 KI mice
display increases in anxiety-like behaviors [29] and that
the SNAP-25 gene is associated with various neuro-
psychiatric disorders, such as schizophrenia [14-17],
ADHD [18-24], and epilepsy [25-29]. Individuals with
each disorder exhibit characteristic behavioral features,
including decreased prepulse inhibition (PPI) in schizo-
phrenia, working memory deficit in schizophrenia and
ADHD, and social deficits in schizophrenia. To further
investigate the behavioral phenotypes related to these
disorders, mutants were subjected to a comprehensive
battery of behavioral tests (Additional file 3) [43]. Regarding
the physical characteristics of the mutants, there were sig-
nificant decreases in body weight (p < 0.0001), grip strength
(p < 0.0001), and wire-hanging time (p < 0.0080), but no
significant difference in body temperature (p = 0.833) or re-
sponse latency in the hot plate test (p = 0.1594), in com-
parison with controls. In the rotarod test, although mutants
failed to exhibit any significant differences in the latencies
to fall both on the first day (Trials 1-3) and the second day
(Trials 4-6), mutant mice had a tendency to have shorter
latencies to fall on the second day (Additional file 1: Figure
S4; Genotype effect: the first day, p = 0.464; the second
day, p = 0.095). The enhanced anxiety-like behavior was
confirmed in the mutants using the light–dark transition
test (Additional file 1: Figure S5). In the open field test,
vertical activity and stereotypic counts were significantly
lower in SNAP-25 KI mice (Additional file 1: Figure S6).
SNAP-25 KI mice tended to travel longer than the control
mice in the early period of the test. After the initial 20-min
period, SNAP-25 KI mice spent most of their time in the
central part of the chamber and their activity level was sig-
nificantly reduced as compared with controls. The mutantsdisplayed abnormal social interactions when placed in a
novel environment (Additional file 1: Figure S7). In the
mutants, the total duration of active contact increased,
and the mean duration per contact decreased. Furthermore,
the number of total contacts appeared to be larger for the
mutants.
PPI, the phenomenon in which a weak prestimulus
suppresses the response to a startling stimulus, is often
decreased in schizophrenic patients compared to healthy
controls [44]. In the mutants, the PPI for the acoustic
startle response was noticeably reduced, with an intensity
of 120 dB for the startle stimulus, compared to that of
controls (Additional file 1: Figure S8). Mutants were also
subjected to the Porsolt forced swim test, which is used to
assess depression-like behavior [45]. There were signifi-
cant decreases in the immobility of the mutants on days 1
and 2, compared to those of controls (Additional file 1:
Figure S9). There were also significant differences between
the genotypes in terms of the distance traveled on days
1 and 2.
The mutants exhibited a severe working memory de-
ficit during a spontaneous alternation task in a modified
automated T-maze (Figure 3H). The mean percentage of
correct responses for mutant mice remained at the
chance level (~50%), whereas the mean percentage of
correct responses for the control mice was greater than
75%. Both the mutants and controls scored at a similar
level in a left-right discrimination task in the T-maze,
but the mutants showed a significantly lower percentage of
correct responses than the controls during the reversal
learning sessions (p = 0.0121; Additional file 1: Figure S10).
Decrease in the expression of destabilized Venus under
the arc promoter in SNAP-25 KI mice
Taken together, our results indicate that the iDG pheno-
type is present in SNAP-25 KI mice. Therefore, it was
expected that stimulation-induced activation of these
cells would also be altered. To address this issue, Arc-
dVenus transgenic mice were used that express the
destabilized Venus (dVenus) fluorescent protein under
the promoter of the immediate early gene (IEG) arc
(a marker for mature in vivo activity-dependent res-
ponses in granule cells) [36,46]. Upon exposure to a new
environment, SNAP-25 KI mice showed lower dVenus
signals in almost all brain regions examined, especially
in the DG and orbitofrontal cortex, compared with con-
trol mice (Figure 4).
Rescue of the iDG phenotype and working memory
deficit in SNAP-25 KI mice by valproate treatment
We have previously reported that epileptic seizures
occur in SNAP-25 KI mice [29]. Therefore, we investi-
gated the ability of treatment with an antiepileptic drug,
valproate, to rescue the iDG phenotype and working
Figure 4 Decrease in dVenus expression after exploration of a novel environment. (A–J) Representative images of dVenus expression in
control (A, B, E–G) and SNAP-25 KI mice (C, D, H–J) are shown. (K, L) dVenus expression levels in different regions of the brain (n = 3 mice
each). OB, olfactory bulb; OC, orbitofrontal cortex; CG, cingulate cortex; MC, motor cortex; DE, dorsal endopiriform nucleus; PI, piriform cortex; SC,
somatosensory cortex; DG, dentate gyrus; CA, cornu ammonis.
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intraperitoneally with valproate (200 mg/kg body weight)
every day for 4 weeks beginning at postnatal day 16.
Interestingly, calbindin immunoreactivity was increased
in valproate-treated SNAP-25 KI mice compared to that
of vehicle-treated SNAP-25 KI mice (Figure 5A, p =
0.0158). However, the level of calbindin expression in
the DG of valproate-treated SNAP-25 KI mice was not
comparable to those of control mice (vehicle-treated
control mice v.s. valproate-treated SNAP-25 KI mice:
p = 0.0806; valproate-treated control mice v.s. valproate-
treated control mice v.s. valproate-treated SNAP-25 KI
mice: p = 0.0158). The number of calretinin-positive
cells in valproate-treated SNAP-25 KI mice was
decreased compared to that of vehicle-treated SNAP-25
KI mice (p = 0.0180), although there were significant
differences in the number of calretinin-positive cells
between valproate-treated SNAP-25 KI mice and vehicle-
or valproate-treated control mice (Figure 5C, Genotype ×
drug: p = 0.0101; vehicle-treated control mice v.s.
valproate-treated SNAP-25 KI mice: p = 0.0165; valpro-
ate-treated control mice v.s. valproate-treated controlmice v.s. valproate-treated SNAP-25 KI mice: p = 0.0271).
DCX-positive cells were located in the subgranular zone
of valproate-treated SNAP-25 KI mice (Figure 5C, Geno-
type × drug: p < 0.0001; vehicle-treated control mice v.s.
valproate-treated SNAP 25 KI mice: p = 0.0271; valproate-
treated control mice v.s. valproate-treated control mice v.
s. valproate-treated SNAP-25 KI mice: p = 0.00658). DGs
from valproate-treated mutant mice were smaller than
those in vehicle-treated mice (Figure 5E). Furthermore, a
working memory deficit was not detected in valproate-
treated SNAP-25 KI mice when compared with vehicle-
treated or valproate-treated control mice (Figure 5F,
Genotype × drug: p = 0.838).
Discussion
This study demonstrated that the features of the DG
neurons in SNAP-25 KI mice were strikingly similar to
those of immature DG neurons in normal rodents. A
severe impairment in the working memory of SNAP-25
KI mice was observed during the T-maze spontaneous
alternation test, which is a behavioral task dependent on
hippocampal function. Spontaneous, generalized seizures
Figure 5 Rescue of the immature state of the DG and working memory deficit in SNAP-25 KI mice by valproate treatments. (A-D)
Effects of chronic valproate treatment beginning on postnatal day 16 on the expression levels of calbindin, calretinin, and DCX in the DG (n = 3
mice each). (E) Effects of valproate administration on enlargement of the DG (n = 3 mice each). (F) Effects of valproate treatment on the working
memory deficit in mutants (control vehicle: n = 3, control valproate: n = 8, KI vehicle: n = 3, KI valproate: n = 7).
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cortex and hippocampus occurred after postnatal days
21–24 in SNAP-25 KI mice [29]. The results of this
study also showed that valproate treatment rescued the
iDG phenotype and working memory deficit in SNAP-25
KI mice. These results suggest that the Ser187 mutation
in SNAP-25 causes the iDG phenotype and working
memory deficit by inducing epilepsy. This interpretation
is consistent with recent findings demonstrating that the
pilocarpine-induced epilepsy model also causes the iDG
phenotype [47]. However, the possibility that valproaterescues the phenotype in SNAP-25 KI mice in a manner
independent of epilepsy cannot be excluded at this time.
We previously reported that there are no obvious
differences in brain structures between control and
SNAP-25 KI mice at 2.5 weeks of age [29]. In SNAP-25
KI mice, epilepsy is observed after postnatal day 21–25
[29], and, as observed in the current study, treatment
with the antiepileptic drug valproate rescued the iDG
phenotype, enlargement of the DG, and working mem-
ory deficit. Thus, these findings suggest that epilepsy
after postnatal day 21–25 may convert the hippocampal
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SNAP-25 KI mice and enlarge the DG structure.
While the SNAP-25 mutant protein was constitutively
expressed in mutant mice, it is not clear whether the
iDG phenotype in SNAP-25 KI mice was caused by the
cell autonomous role of SNAP-25. Ser187 of SNAP-25 is
involved in a negative feedback mechanism for con-
trolling neuronal excitability via inhibition of calcium
dynamics [28]. Additionally, as already mentioned,
SNAP-25 KI mice exhibit epileptic seizures after postna-
tal day 21–25. Thus, it is likely that the iDG phenotype
is non-cell autonomously induced via epilepsy in SNAP-
25 KI mice. However, we cannot exclude the possibility
of cell autonomous roles for SNAP-25 in the iDG
phenotype. Further studies will be needed to address cell
autonomous and non-cell autonomous roles of SNAP-25
in the iDG phenotype.
The iDG phenotype has been reported in other mouse
models (e.g., αCaMKII HKO [32], Shn-2 KO [37], and
FLX-treated mice [33]), which exhibit hyperactivity and
a severe working memory deficit. FLX-treated mice
display increased anxiety-like behaviors [48]. In SNAP-
25 KI mice, the iDG phenotype is characterized by com-
mon gene expression patterns (αCaMKII HKO mice
have 204 altered genes in common; Shn-2 KO mice have
248 altered genes in common; and FLX-treated mice
have 246 altered genes in common). Among the altered
genes in SNAP-25 KI mice, 2 main patterns were identi-
fied: 1) upregulation of calretinin, brain-derived neuro-
trophic factor (BDNF), and glial fibrillary acidic protein
(GFAP), and 2) downregulation of calbindin, TDO2, and
DSP. Using patch-clamp analysis, granule cells in the
iDG were also shown to exhibit electrophysiological
features similar to those of immature granule cells,
including a depolarized resting membrane potential and
a lower threshold current for firing. An increased
number of spikes during sustained depolarization was
also observed, which is similar to the properties of
dematurated granule cells after FLX treatment [33]. This
result indicates that granule cells in the iDG phenotype
are more excitable than mature granule cells. In
contrast, differences in gene expression patterns and
adult neurogenesis in the DG were discovered in mice
possessing the iDG phenotype. In SNAP-25 KI mice,
little adult neurogenesis can be seen, while adult neuro-
genesis is increased in αCaMKII HKO [32], Shn-2 KO
[37], and FLX-treated mice [39]. Although the expres-
sion of DRD1A mRNA increased in all mouse strains
and in FLX-treated mice, the magnitude of the increase
in αCaMKII HKO and Shn-2 KO mice (< 2.5-fold) was
smaller than in SNAP-25 KI and FLX-treated mice (> 7-
fold). Therefore, these results suggest that future
characterization of the iDG phenotype will include the
above-described features along with properties that arecurrently unknown. Recently, increased expression of
the immature granule cell marker calretinin was ob-
served in the DG of patients with schizophrenia and
bipolar disorder [49]. These data indicate that the iDG
phenotype exists not only in mouse models, but also in
humans with certain types of psychiatric disorders.
One of the behavioral abnormalities that mice with the
iDG phenotype, such as SNAP-25 KI, αCaMKII HKO,
and Shn-2 KO mice, have in common is a severe work-
ing memory deficit. This finding suggests that a working
memory deficit is associated with the iDG phenotype.
Using Arc-dVenus transgenic mice, we demonstrated in
the current study that the expression of dVenus is
dramatically decreased in all of the brain regions exam-
ined, especially in the DG and orbitofrontal cortex,
which are involved in working memory. Anatomically, a
monosynaptic pathway exists between the hippocampus
and the medial prefrontal cortex. Axons from the hip-
pocampal CA1/subiculum fields innervate the prelimbic/
medial orbitofrontal cortex [50]. Disruption of the
hippocampal-prefrontal pathway impairs the perform-
ance of rats in a spatial working memory task [51].
Furthermore, simultaneous tetrode recordings from the
rat hippocampus and orbitofrontal cortex revealed that
the activity in these different regions may be synchro-
nized during a spatial working memory task [52]. Thus,
the iDG phenotype may be the cause of the working
memory deficit in the SNAP-25 KI mice in our study. A
working memory deficit is known to be present in pa-
tients with schizophrenia [53], ADHD [54], and anxiety
disorder [55]. The DG is reported to play an important
role in working memory function [56]. Future studies,
using different techniques such as conditional gene abla-
tion and optogenetics, are needed to elucidate the exact
causal relationship between the iDG phenotype and a
working memory deficit.
The mechanism through which the iDG phenotype is
induced is still unclear. However, previous studies have
suggested that epilepsy is a candidate for producing the
iDG phenotype. A long-term reduction in calbindin
mRNA and protein expression has been observed in the
hippocampi of rats following pilocarpine treatment [57].
A similar reduction in calbindin has been reported in
human epileptic brains examined postmortem [58,59].
These findings suggest that epilepsy may induce the iDG
phenotype by dematuration of mature granule cells.
Furthermore, recent findings have shown that mice ex-
periencing seizures induced by pilocarpine also exhibit
the molecular characteristics of the iDG phenotype and
associated behavioral abnormalities, which are similar to
the abnormalities observed in αCaMKII HKO mice [47].
Moreover, valproate has been shown to suppress the
iDG phenotype (present study, Figure 5) as well as
seizures (previous study, ref. [60]). Taken together, this
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mice may be induced by epilepsy and may result in
behavioral deficits. However, the possibility that causes
other than epilepsy may induce the iDG phenotype in
SNAP-25 KI mice cannot be excluded. Future studies
are needed to elucidate the exact relationship between
the SNAP-25 mutation and the induction of the iDG
phenotype.
The transcriptome data for SNAP-25 KI mice were
similar to those of FLX-treated mice (see Figure 3A),
suggesting that similar molecular events may occur in
the DGs of SNAP-25 KI and FLX-treated mice. There-
fore, one might wonder whether valproate treatment
also reverses the FLX-induced dematuration phenotype.
However, currently, it remains unclear whether valproate
treatment can reverse the FLX-induced dematuration of
hippocampal granule cells or enhance the effects of FLX
on dematuration. It is of interest to examine whether
valproate treatment enhances or reverses the effects of
FLX on dematuration.
SNAP-25 KI mice may have endophenotypes other
than the iDG phenotype in the brain. Endophenotypes
which have been already found in mice with the iDG
phenotype other than SNAP-25 KI mice, such as Shn-2
KO and FLX-treated mice, may be tested as a shortcut
to identifying endophenotypes other than the iDG
phenotype in the brains of SNAP-25 KI mice. Shn-2 KO
mice show mild chronic inflammation in the frontal
cortex and hippocampus, decreased expression of oligo-
dendrocyte markers in the hippocampus, and reduced
numbers of parvalbumin-positive neurons in the frontal
cortex and hippocampal CA1 [37]. FLX-treated mice
exhibit dematuration of the neurons in the visual cortex
[61], amygdala [62], and DG [33], enhanced expression
of BDNF [63], decreased adult neurogenesis in the
subventricular zone [39,64], and induction of GABAergic
interneurons from the neural progenitor L1-INP cells in
the adult cortex [65]. It would be worthwhile to assess
these endophenotypes in SNAP-25 KI mice in the
future.
Psychiatric disorders, including anxiety disorder, ADHD,
and schizophrenia [66-68], have been reported to accom-
pany epilepsy. For example, 19% of patients with temporal
lobe epilepsy are diagnosed with an anxiety disorder [69].
ADHD is another common psychiatric comorbidity in
patients with epilepsy, and 20% of patients with epilepsy
exhibit features of ADHD [70]. Furthermore, appro-
ximately half of all epileptic patients with psychosis are
diagnosed with schizophrenia [71]. Interestingly, in a con-
vergent functional genomics study identifying candidate
genes for schizophrenia, 42 candidate genes were named
[30]. Altered expression patterns were identified in SNAP-
25 KI mice in 18 of these top 42 candidate genes for
schizophrenia (Additional file 4) [30]. Strong evidencesuggests that individuals with schizophrenia exhibit al-
tered gene expression of MIR137, the gene encoding the
miRNA miR-137 [72,73]. miR-137 expression is enriched
in the hippocampus [74], especially in the DG [75]. A
functional target of miR-137 is mind bomb-1 (MIB1),
which facilitates neuron maturation [75]. In SNAP-25 KI
mice, the expression of MIB1 was significantly decreased
(Additional file 4), consistent with these previous studies.
Research investigating the relationship between the
iDG phenotype and psychiatric disorders involving
psychosis is in its infancy. However, recent studies have
suggested that the iDG phenotype is involved in psych-
osis. The iDG phenotype has been observed in putative
mouse models for schizophrenia, bipolar disorder,
ADHD, and epilepsy [32,37,48,76]. A microarray analysis
of post-mortem schizophrenic human brains revealed a
significant reduction in hippocampal calbindin gene
expression [77]. Previous reports have shown that the
expression of calretinin, an immature granule cell marker,
was significantly higher in postmortem brains of patients
with schizophrenia and bipolar disorder compared to
controls [49]. In addition, the increased expression of
calretinin in patients with schizophrenia and bipolar
disorder is closely associated with a diagnosis of psychosis
and death due to suicide [49]. Therefore, it is likely that
the iDG phenotype represents an endophenotype that
causes cognitive deficits and psychosis, symptoms shared
by these disorders. Tamminga et al. hypothesized that a
reduction in glutamatergic transmission in the DG de-
creases the hippocampal pattern separation, which is a
representation of inputs that have strong temporal and
spatial similarities. This condition may result in false asso-
ciations that govern some of the symptoms of psychosis,
such as delusions and thought disorders [78]. The current
results are consistent with this hypothesis.
In conclusion, our current data, together with previous
findings, suggest that the iDG phenotype is responsible
for some of the cognitive deficits observed in SNAP-25
KI, αCaMKII HKO, Shn-2 KO, and pilocarpine-treated
mice and in patients with psychiatric disorders, such as
schizophrenia, ADHD, and anxiety disorder.
Methods
Animals and drug administration
Mice heterozygous for the snap-25S187A locus were bred
to each other and maintained following standard hus-
bandry procedures [29]. Genotyping of the mice was
performed by PCR. Wild-type littermates were used as
controls for the experiments.
Arc-dVenus transgenic mice have been described in
previous studies [36,46]. SNAP-25 KI mice were bred
onto a C57BL/6N background, and Arc-dVenus trans-
genic mice were maintained in the C57BL/6J back-
ground. SNAP-25 KI mice were crossed to Arc-dVenus
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generate F2 offspring (SNAP-25 KI/Arc-dVenus: SNAP-
25 wild/Arc-dVenus).
BrdU labeling was performed following a previously
described protocol [39]. Briefly, the animals were in-
jected intraperitoneally with BrdU (Sigma-Aldrich, St.
Louis, MO; 100 mg/kg body weight) every 24 h for 3 days
prior to fixation.
The administration of valproate was initiated on post-
natal day 16. Mice were given valproate (200 mg/kg
body weight) by intraperitoneal injection at 10:00 a.m.
each day for 4 weeks. Mice were fixed with 4% parafor-
maldehyde for 6 h after the last injection.
All of the animal experiments were approved by the
Institutional Animal Care and Use Committee of Fujita
Health University and Graduate School of Medicine,
Kyoto University, based on the Law for the Humane
Treatment and Management of Animals (2005) and the
Standards Relating to the Care and Management of
Laboratory Animals and Relief of Pain (2006). Every
effort was made to minimize the number of animals used.Immunohistological analysis
Fixation and immunofluorescent staining were performed
following a previously described protocol [79]. The
sections were incubated at room temperature overnight
with the indicated primary antibodies. After incubation
with the secondary antibody, sections were mounted onto
glass slides and embedded with Permafluor (Thermo,
Waltham, MA). We used a confocal laser-scanning mi-
croscope (LSM 700; Carl Zeiss, Göttingen, Germany) to
obtain images of the stained sections.
For NeuN immunohistochemistry, the sections were
incubated at room temperature overnight in anti-NeuN
antibody (diluted 1:1000, Millipore, Billerica, MA). Sec-
tions were then incubated with a biotinylated secondary
antibody at room temperature for 2 h. The immunoreac-
tive sites were visualized using the avidin-biotin complex
peroxidase method with an avidin-biotin complex kit
(ABC kit, Vector Laboratories, Burlingame, CA). A 3,30-
diaminobenzidine tetrahydrochloride, 4HC1 (DAB) so-
lution containing 0.3% nickel ammonium sulfate in 0.05
M Tris–HCl, pH 7.6, was used as the substrate for
peroxidase.
Quantification analysis was performed using a confocal
microscope equipped with a 40× objective lens (Plan-
NEOFLUAR, NA = 0.75, Carl Zeiss) and a pinhole setting
that corresponded to a focal plane thickness of less than
1 μm. To avoid false positives caused by overlapping
signals from different cells, randomly selected positive
cells were analyzed by moving through the entire z-axis of
each cell. Cells were counted under the live mode setting
on the confocal microscope.The number of immunoreactive cells was counted
using ImageJ with the WCIF ImageJ bundle (http://
www.uhnres.utoronto.ca/facilities/wcif/). Images from
the confocal microscope were converted into 8-bit
black-and-white images. Image thresholds were automat-
ically determined by a plugin “maximum entropy thresh-
old”, and binary images were generated. Once the
images were segmented, the number of immunopositive
cells was automatically generated using the command
“Analyze/Analyze particles”. To exclude objects that
were clearly not objects of interest in the binary image,
the minimum size and maximum size were set to a
range of 5–25 μm, which corresponds to the neuron cell
body size.
Antibodies
For primary antibodies, we used mouse monoclonal
antibodies against calbindin (1:2000, Sigma-Aldrich),
calretinin (1:10000, Millipore, Billerica, MA), NeuN
(1:200 for immunofluorescent staining; 1:1000 for DAB
staining), and parvalbumin (1:2,000, Sigma-Aldrich); a
rat monoclonal antibody against BrdU (1:100, Abcam,
Cambridge, MA); a rabbit polyclonal antibody against
Ki-67 (1:10, Ylem, Avezzano, Italy), and a goat polyclonal
antibody against DCX (1:200, Santa Cruz Biotechnology,
Santa Cruz, CA). For secondary antibodies, we used
anti-mouse IgG Alexa 488 (1:200, Invitrogen, Carlsbad,
CA), anti-mouse IgG Alexa 594 (1:200, Invitrogen), anti-
rat IgG Alexa 594 (1:200, Invitrogen), anti-rabbit IgG
Alexa 488 (1:200, Invitrogen), anti-rabbit IgG Alexa
594 (1:200, Invitrogen), and anti-mouse IgG Biotin-
conjugated (1:200, Vector Laboratories).
Electrophysiology
Transverse hippocampal slices (20- to 32-week-old mice)
were prepared, and electrophysiologic recordings were
taken following a previously described protocol [32,33].
Mice were decapitated under halothane anesthesia, and
both hippocampi were isolated. Transverse hippocampal
slices (380 μm) were cut using a tissue slicer. Elec-
trophysiological recordings were taken in a submersion-
type chamber superfused at 2 mL/min with standard
saline composed of the following (in mM): NaCl, 125;
KCl, 2.5; NaH2PO4, 1.0; NaHCO3, 26.2; glucose, 11;
CaCl2, 2.5; MgCl2, 1.3 (equilibrated with 95% O2/5%
CO2) and maintained at 27–27.5°C. Whole-cell recor-
dings were taken from granule cells in the DG using the
blind whole-cell patch-clamp technique. Current-clamp
recordings were taken using a pipette filled with a solu-
tion composed of the following (in mM): potassium
gluconate, 140; HEPES, 20; NaCl, 8; MgATP, 2; Na2GTP,
0.3; EGTA, 0.05 (pH adjusted to 7.2 with KOH). The
recording pipette was placed in the middle third of the
GCL. Hyperpolarizing and depolarizing currents (400 ms)
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the input resistance and to evaluate the action potential
firing properties, respectively. Field excitatory postsynaptic
potentials (EPSPs) at the MF-CA3 synapse were recorded
in the stratum lucidum of the hippocampal CA3 region
using a glass electrode filled with 2 M NaCl. Bipolar
stimulating electrodes were placed in the GCL, and EPSPs
were evoked at a frequency of 0.05 Hz unless otherwise
specified. All recordings were taken using a Multiclamp
700B amplifier (Molecular Devices, Sunnyvale, CA), fil-
tered at 2–10 kHz and stored in a personal computer
using a digital interface (digitized at 5–20 kHz).
Quantitative real-time PCR
Quantitative real-time PCR was performed following a
previously described protocol [32]. Briefly, total RNA
was isolated from the hippocampi of 3-month-old con-
trol and mutant mice. First-strand cDNA was prepared
from 2 μg of DNase I-treated total RNA using Super-
Script III reverse transcriptase (Invitrogen). PCR was
performed using the DNA Engine Opticon 2 Real-Time
PCR System (Bio-Rad, Hercules, CA) under the follow-
ing conditions: 15 min at 95°C, followed by 45 cycles of
15 s at 94°C, 30 s at 60°C, 30 s at 72°C, and then 1 min
at 65°C. β-Actin was amplified from all samples to
normalize expression. The following primers were used:
DRD1A (1–124), 50-ATGGCTCCTAACACTTCTACCA
and 50-GGGTATTCCCTAAGAGAGTGGAC; TDO2 (1–
105), 50-ATGAGTGGGTGCCCGTTTG and 50-GGCTCT
GTTTACACCAGTTTGAG; DSP (7–113), 50-GCTGAAG
AACACTCTAGCCCA and 50-ACTGCTGTTTCCTCTG
AGACA; β-actin (851–962), 50-AGTGTGACGTTGACAT
CCGTA and 50-GCCAGAGCAGTAATCTCCTTCT.
DNA microarray analysis
Microarray experiments were performed with hippo-
campi isolated from control and mutant male mice (25–
40 weeks old, 7 control mice, 6 mutant mice) following
a previously described protocol [32]. Briefly, RNA was
isolated from brain tissues using the TRIzol method
(Invitrogen), followed by purification using RNeasy
columns (Qiagen, Valencia, CA). Double-stranded cDNA
was synthesized from the total RNA, and an in vitro
transcription reaction was then performed on biotin-
labeled RNA that was generated using the cDNA.
Labeled RNA was hybridized to the Mouse Genome 430
2.0 Array (Affymetrix, Santa Clara, CA), which contains
45101 probe sets, and the array was washed according
to the manufacturer’s recommendations. The hybridized
probe array was then stained with streptavidin-conjugated
phycoerythrin, and each GeneChip was scanned using
an Affymetrix GeneChip Scanner 3000 (GCS3000). The
raw data were corrected for background using the robust
multichip average (RMA) algorithm and quantile nor-malization [80] in the Affymetrix Expression Console 1.1
software. To determine whether there were differences in
gene expression between 2 groups, a 2-tailed, unpaired
Welch t-test was performed on the normalized data set.
Only genes with p-values less than 0.05 and absolute
values of FC greater than 1.2 were considered to be differ-
entially expressed. Expression data and other information
used in this paper will be available on the ArrayExpress
database. Public microarray datasets were queried using
NextBio [81], which is a database of microarray results
(data used in Additional file 2 was accessed on February 1,
2012, and data used in Additional file 4 was accessed on
May 25, 2012). NextBio is a repository of analyzed micro-
array datasets that allows the investigator to search results
and expression profiles of publicly available microarray
datasets. Gene overlaps were examined using Running
Fisher tests.Exposure to a new environment
Before exposure to a new cage, each SNAP-25 KI/Arc-
dVenus and SNAP-25 wild-type/Arc-dVenus mouse was
housed in a standard cage for 24 h. For the new cage ex-
posure, 3 mice were housed together in a new cage that
included new paper tips, some types of nuts, and 2
neslets. Mice were euthanized and brain tissues were
fixed 5 h after exposure to the new cages, when dVenus
was expressed at its maximum level [36,46].T-maze spontaneous alternation task
The spontaneous alternation task was conducted using a
modified T-maze apparatus and an automated video-
tracking system (available through O’Hara & Co., Tokyo,
Japan) [82,83]. The apparatus was constructed of white
plastic runways with 25-cm high walls. It was partitioned
into 6 areas by sliding doors that could be automatically
opened by sliding downward. The stem of the T was
designated as area S2 (13 × 24 cm), and the arms of the
T were designated as areas A1 and A2 (11.5 × 20.5 cm).
Areas P1 and P2 were the connecting passageways from
the arms (area A1 or A2) to the start compartment (area
S1). Mice were placed in the S1 area and immediately
subjected to a forced-choice run (pseudo-randomly
assigned to either left or right arms). Mice were held in
either one of the arms (area A1 or A2) for 10 s. There-
after, the door was opened so that the mouse could go
back to the start area S1. They were held in the S1 area
for 3 s and were then subjected to a free-choice run in
which they were given access to both arms. This se-
quence (trial) was repeated 10 times per day (cutoff
time, 7200 s). The intertrial intervals were 60 s. The per-
centage of trials in which mice entered the arm opposite
to its forced-choice run during the free-choice run was
calculated as the percentage of correct responses. Data
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ImageTM software.
Neuromuscular strength
Neuromuscular strength was tested using the grip
strength and wire-hang tests. A grip strength meter
(O’Hara & Co.) was used to assess the forelimb grip
strength. Mice were lifted and held by their tails so that
their forepaws could grasp a wire grid. The mice were
then gently pulled backward by the tail, with their body
parallel to the surface of the table, until they released
the grid. The peak force applied by the mouse forelimbs
was recorded in Newtons (N). Each mouse was tested 3
times, and the greatest value measured was used for sta-
tistical analysis. In the wire hang test, the mouse was
placed on a wire mesh that was then inverted and gently
waved to cause the mouse to grip the wire. The amount
of time that passed before the mouse fell was recorded,
with a 60-s cut-off time.
Light/dark transition test
The light/dark transition test was conducted as previ-
ously described [84]. The apparatus used for the light/
dark transition test consisted of a cage (21 × 42 × 25 cm)
divided into 2 sections of equal size by a partition that
contained a door (O’Hara & Co.). One chamber was
brightly lit (390 lux), and the other chamber was dark
(2 lux). Mice were placed in the dark side and allowed to
move freely between the 2 chambers with the door open
for 10 min. The total number of transitions between the
chambers, the time spent in each side, the amount of time
it took the mouse to first enter the light side, and the
distance traveled were automatically recorded.
Open-field test
Locomotor activity was measured using an open-field
test. Each subject was allowed to move freely in the
open-field apparatus (40 × 40 × 30 cm; AccuScan Instru-
ments, Columbus, OH, USA) equipped with photocells
(beam spacing 2.5 cm, beam diameter 4 mm, beam
frequency 50 cycles/s). The total distance traveled, verti-
cal activity (rearing measured by counting the number
of photobeam interruptions), time spent in the center
area of the open field, and counts of stereotypic behavior
were recorded using the VersaMax system (AccuScan
Instruments). The center area was defined as the central
20 × 20 cm portion. If a mouse stays in the area, then a
mouse was considered to be in the center area. If a
mouse broke the same beam (or set of beams) repeat-
edly, then it was considered to be exhibiting stereotypic
activity. This type of activity is often exhibited as grooming
or head bobbing behaviors. Stereotypic counts are the
number of beam breaks that occur during any period of
stereotypic activity. Data were collected for 120 min.Elevated plus-maze test
The elevated plus-maze test was conducted as previously
described [85]. The elevated plus-maze consisted of
2 open arms and 2 enclosed arms of the same size (25 ×
5 cm) with 15-cm high transparent walls. The arms and
central square were made of white plastic plates that
were elevated 55 cm above the floor. To minimize the
likelihood of animals falling from the apparatus, 3-mm
high Plexiglas walls surrounded the sides of the open
arms. Arms of the same type were located opposite from
each other. Each mouse was placed in the central square
of the maze (5 × 5 cm) facing one of the closed arms.
Mouse behavior was recorded during a 10-min test
period. The number of entries into an arm and the times
spent in the open and enclosed arms were recorded. The
percentage of entries into open arms, time spent in open
arms (s), number of total entries, and total distance trav-
eled (cm) were analyzed. Data acquisition and analysis
were automatically performed using ImageEP software.
Hot plate test
The hot plate test was used to evaluate sensitivity to a
painful stimulus. Mice were placed on a 55.0 ± 0.3°C hot
plate (Columbus Instruments), and the amount of time
that passed before the first hind-paw response was
recorded. The hind-paw response was defined as either a
foot shake or a paw lick.
Social interaction test in a novel environment
The social interaction test was conducted as previously
described [86]. Two mice of identical genotypes that
were previously housed in different cages were placed
into a box together (40 × 40 × 30 cm) and allowed to
freely explore for 10 min. Their social behavior was
monitored using a CCD camera. Analyses were automa-
tically performed using ImageSI software. The total dur-
ation of contacts, the number of contacts, the number of
active contacts, mean duration per of each contact, and
total distance traveled were measured. The number of
active contacts was defined as follows. Images were cap-
tured at a rate of 1 frame per second, and the distance
traveled between 2 successive frames was calculated for
each mouse. If the 2 mice contacted each other and the
distance traveled by either mouse was longer than 5 cm,
then the behavior was considered to be ‘active contact’.
Rotarod test
Motor coordination and balance were tested using the
rotarod test. The rotarod test, using an accelerating
rotarod (UGO Basile, Comerio, Italy), was performed by
placing mice on rotating drums (3 cm in diameter) and
measuring the time each animal was able to maintain its
balance on the rod. The speed of the rotarod accelerated
from 4 to 40 rpm over a 5-min period.
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A startle reflex measurement system (O’Hara & Co.)
was used to measure the startle response and prepulse
inhibition. A test session began by placing a mouse in a
plastic cylinder that was left undisturbed for 10 min.
White noise (40 ms) was used as the startle stimulus for
all trial types. The startle response was recorded for
140 ms (measuring the response every 1 ms) starting
with the onset of the prepulse stimulus. The background
noise level in each chamber was 70 dB. The peak startle
amplitude recorded during the 140 ms sampling window
was used as the dependent variable. A test session
consisted of 6 trial types (i.e., 2 types for startle stimulus
only trials and 4 types for prepulse inhibition trials). The
intensity of the startle stimulus was 110 or 120 dB. The
prepulse sound was given 100 ms before the startle
stimulus, and its intensity was 74 or 78 dB. Four combina-
tions of prepulse and startle stimuli were used (74/110,
78/110, 74/120, and 78/120 dB). Six blocks of the 6 trial
types were presented in pseudorandom order such that
each trial type was presented once within a block. The
average intertrial interval was 15 s (range, 10–20 s).
Porsolt forced swim test
The apparatus consisted of 4 Plexiglas cylinders (20 cm
height × 10 cm diameter). The cylinders were filled with
water (23°C) up to a height of 7.5 cm. Mice were placed
in the cylinders, and their immobility and the distance
traveled were recorded over a 10-min test period. Images
were captured at a rate of 1 frame per second. For each
pair of successive frames, the amount of area (pixels)
that the mouse moved was measured. When the amount
of area was below a certain threshold, the mouse beha-
vior was judged to be “immobile.” When the amount of
area equaled or exceeded the threshold, the mouse was
considered to be “moving.” The optimal threshold used
to judge mobility was determined by adjusting it to the
amount of immobility measured by human observation.
Immobility lasting less than 2 s was not included in the
analysis. Data acquisition and analysis were automatically
performed using the ImageJ-based original program,
ImagePS (see “Image Analysis”).
Y-maze test
Exploratory activity was measured using a Y-maze appar-
atus (arm length: 40 cm, arm bottom width: 3 cm, arm
upper width: 10 cm, height of wall: 12 cm). Each mouse
was placed in the center of the Y-maze field. The number
of entries and changes in direction were recorded using
ImageYM software. Data were collected for 10 min.
Image analysis
The applications used for the behavioral studies (ImagePS,
ImageLD, ImageEP, ImageTM, ImageYM, ImageSI) werebased on the public domain programs NIH Image and
ImageJ (developed at the U.S. National Institutes of Health
and available on the Internet at http://rsb.info.nih.gov/ij/),
which were modified for each test by Tsuyoshi Miyakawa
(available through O’Hara & Co.).
Statistical analysis
Statistical analysis was conducted using StatView (SAS
Institute, Cary, NC, USA). Data were analyzed by one-
way Analysis of Variance (ANOVA), two-way ANOVA,
or two-way repeated measures ANOVA, unless other-
wise noted. Post hoc analyses were performed on all
ANOVAs found to be significant. The values in graphs
are expressed as the means ± SEM. Effect sizes were
calculated according to the Hedges’ g.
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